Table 2. Patient characteristics (risk... | American Society of Hematology

Table 2.

Patient characteristics (risk factors for poor outcome)

Factor	Incidence (N = 31)
Factor	No.	%
Stage IV disease	10	32.3
Primary refractory disease*	10	32.3
Extranodal disease	16	51.6
≥3 lines of previous treatment	24	77.4
Metabolically active disease at transplant	24	77.4
WHO performance status
0	29	93.5
1	2	6.5

Factor	Incidence (N = 31)
Factor	No.	%
Stage IV disease	10	32.3
Primary refractory disease*	10	32.3
Extranodal disease	16	51.6
≥3 lines of previous treatment	24	77.4
Metabolically active disease at transplant	24	77.4
WHO performance status
0	29	93.5
1	2	6.5

Median time from diagnosis to relapse in the cohort of 21 patients with relapsed disease was 10.5 months (range, 3.4-121.9 months).